Crossmark

Low-dose pembrolizumab re-treatment induced complete radiologic and molecular remission in Hodgkin lymphoma recurring from a previous relapse successfully treated by pembrolizumab

Crossref DOI link: https://doi.org/10.1007/s00277-019-03762-3

Published Online: 2019-07-22

Published Print: 2019-10

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Kwong, Yok-Lam https://orcid.org/0000-0001-8156-6978
Loong, Florence

Khong, Pek-Lan
License Information

Text and Data Mining valid from 2019-07-22

Version of Record valid from 2019-07-22
More Information

Article History

Received: 4 May 2019

Accepted: 14 July 2019

First Online: 22 July 2019

Compliance with ethical standards

:

: The authors declare that they have no conflict of interest.

: Not applicable.

: Patient gave informed consent to treatment.

Document is current

Any future updates will be listed below